HSPA9 and cancer: Several observations have suggested that mortalin is involved in the transformation of normal cells to cancer cells [15], in a process that involves mortalin interaction with p53 promoting sequestration of p53 in the cytoplasm, thereby inhibiting its nuclear activity [16].